Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

被引:62
作者
Balcar, Lorenz [1 ,2 ]
Tonon, Marta [3 ]
Semmler, Georg [1 ,2 ]
Calvino, Valeria [3 ]
Hartl, Lukas [1 ,2 ]
Incicco, Simone [3 ]
Jachs, Mathias [1 ,2 ]
Bauer, David [1 ,2 ]
Hofer, Benedikt Silvester [1 ,2 ,4 ]
Gambino, Carmine Gabriele [3 ]
Accetta, Antonio [3 ]
Brocca, Alessandra [3 ]
Trauner, Michael [1 ]
Mandorfer, Mattias [1 ,2 ]
Piano, Salvatore [3 ]
Reiberger, Thomas [1 ,2 ,4 ,5 ]
Baveno Cooperation EASL consortium
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Univ Padua, Dept Med, Unit Internal Med & Hepatol, Padua, Italy
[4] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fib, Vienna, Austria
[5] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
关键词
Portal hypertension; Hepatic decompensation; Spontaneous bacterial peritonitis; Acute kidney injury; Baveno; QUALITY-OF-LIFE; NATURAL-HISTORY; CLINICAL-COURSE; PROGNOSTIC INDICATORS; HEPATORENAL-SYNDROME; REFRACTORY ASCITES; COMPETING RISKS; RENAL-FAILURE; MORTALITY; SURVIVAL;
D O I
10.1016/j.jhepr.2022.100513
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Although ascites is the most frequent first decompensating event in cirrhosis, the clinical course after ascites as the single index decompensation is not well defined. The aim of this multicentre study was thus to systematically investigate the incidence and type of further decompensation after ascites as the first decompensating event and to assess risk factors for mortality. Methods: A total of 622 patients with cirrhosis presenting with grade 2/3 ascites as the single index decompensating event at 2 university hospitals (Padova and Vienna) between 2003 and 2021 were included. Events of further decompensation, liver transplantation, and death were recorded.Results: The mean age was 57 +/- 11 years, and most patients were male (n = 423, 68%) with alcohol-related (n = 366, 59%) and viral (n = 200,32%) liver disease as the main aetiologies. In total, 323 (52%) patients presented with grade 2 and 299 (48%) with grade 3 ascites. The median Child-Pugh score at presentation was 8 (IQR 7-9), and the mean model for end-stage liver disease (MELD) was 15 +/- 6. During a median follow-up period of 49 months, 350 (56%) patients experienced further decompensation: refractory ascites (n = 130, 21%), hepatic encephalopathy (n = 112, 18%), spontaneous bacterial peritonitis (n = 32, 5%), hep-atorenal syndrome-acute kidney injury (n = 29, 5%). Variceal bleeding as an isolated further decompensation event was rare (n = 18, 3%), whereas non-bleeding further decompensation (n = 161, 26%) and >-2 concomitant further decompensation events (n = 171, 27%) were frequent. Transjugular intrahepatic portosystemic shunt was used in only 81 (13%) patients. In patients presenting with grade 2 ascites, MELD >-15 indicated a considerable risk for further decompensation (subdistribution hazard ratio [SHR] 2.18; p <0.001; 1-year incidences: <10: 10% vs. 10-14: 13% vs. >-15: 28%) and of mortality (SHR 1.89; p = 0.004; 1 -year incidences: <10: 3% vs. 10-14: 6% vs. >-15: 14%). Importantly, mortality was similarly high throughout MELD strata in grade 3 ascites (p = n.s. for different MELD strata; 1-year incidences: <10: 14% vs. 10-14: 15% vs. >-15: 20%).Conclusions: Further decompensation is frequent in patients with ascites as a single index decompensation event and only rarely owing to bleeding. Although patients with grade 2 ascites and MELD <15 seem to have a favourable prognosis, those with grade 3 ascites are at a high risk of mortality across all MELD strata. Lay summary: Decompensation (the development of symptoms as a result of worsening liver function) marks a turning point in the disease course for patients with cirrhosis. Ascites (i.e., the accumulation of fluid in the abdomen) is the most common first decompensating event, yet little is known about the clinical course of patients who develop ascites as a single first decompensating event. Herein, we show that the severity of ascites is associated with mortality and that in patients with moderate ascites, the widely used prognostic MELD score can predict patient outcomes.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 29 条
[1]   Long-term Clinical Course of Decompensated Alcoholic Cirrhosis A Prospective Study of 165 Patients [J].
Antonio Alvarez, Marco ;
Cirera, Isabel ;
Sola, Ricard ;
Bargallo, Ana ;
Maria Morillas, Rosa ;
Planas, Ramon .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (10) :906-911
[2]  
Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
[3]   Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites [J].
Bureau, Christophe ;
Thabut, Dominique ;
Oberti, Frederic ;
Dharancy, Sebastien ;
Carbonell, Nicolas ;
Bouvier, Antoine ;
Mathurin, Philippe ;
Otal, Philippe ;
Cabarrou, Pauline ;
Peron, Jean Marie ;
Vinel, Jean Pierre .
GASTROENTEROLOGY, 2017, 152 (01) :157-163
[4]   Quality of life in refractory ascites: Transjugular intrahepatic portal-systemic shunting versus medical therapy [J].
Campbell, NS ;
Brensinger, CM ;
Sanyal, AJ ;
Gennings, C ;
Wong, F ;
Kowdley, KV ;
McCashland, T ;
Reddy, KR .
HEPATOLOGY, 2005, 42 (03) :635-640
[5]   Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial [J].
Caraceni, Paolo ;
Riggio, Oliviero ;
Angeli, Paolo ;
Alessandria, Carlo ;
Neri, Sergio ;
Foschi, Francesco G. ;
Levantesi, Fabio ;
Airoldi, Aldo ;
Boccia, Sergio ;
Svegliati-Baroni, Gianluca ;
Fagiuoli, Stefano ;
Romanelli, Roberto G. ;
Cozzolongo, Raffaele ;
Di Marco, Vito ;
Sangiovanni, Vincenzo ;
Morisco, Filomena ;
Toniutto, Pierluigi ;
Tortora, Annalisa ;
De Marco, Rosanna ;
Angelico, Mario ;
Cacciola, Irene ;
Elia, Gianfranco ;
Federico, Alessandro ;
Massironi, Sara ;
Guarisco, Riccardo ;
Galioto, Alessandra ;
Ballardini, Giorgio ;
Rendina, Maria ;
Nardelli, Silvia ;
Piano, Salvatore ;
Elia, Chiara ;
Prestianni, Loredana ;
Cappa, Federica Mirici ;
Cesarini, Lucia ;
Simone, Loredana ;
Pasquale, Chiara ;
Cavallin, Marta ;
Andrealli, Alida ;
Fidone, Federica ;
Ruggeri, Matteo ;
Roncadori, Andrea ;
Baldassarre, Maurizio ;
Tufoni, Manuel ;
Zaccherini, Giacomo ;
Bernardi, Mauro .
LANCET, 2018, 391 (10138) :2417-2429
[6]   Renal failure after upper gastrointestinal bleeding in cirrhosis:: Incidence, clinical course, predictive factors, and short-term prognosis [J].
Cárdenas, A ;
Ginès, P ;
Uriz, J ;
Bessa, X ;
Salmerón, JM ;
Mas, A ;
Ortega, R ;
Calahorra, B ;
De las Heras, D ;
Bosch, J ;
Arroyo, V ;
Rodes, J .
HEPATOLOGY, 2001, 34 (04) :671-676
[7]  
García-Pagán JC, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100122
[8]   Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality [J].
Costa, Dalila ;
Simbrunner, Benedikt ;
Jachs, Mathias ;
Hartl, Lukas ;
Bauer, David ;
Paternostro, Rafael ;
Schwabl, Philipp ;
Scheiner, Bernhard ;
Stattermayer, Albert Friedrich ;
Pinter, Matthias ;
Trauner, Michael ;
Mandorfer, Mattias ;
Reiberger, Thomas .
JOURNAL OF HEPATOLOGY, 2021, 74 (04) :819-828
[9]   Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR [J].
D'Ambrosio, Roberta ;
Degasperi, Elisabetta ;
Anolli, Maria Paola ;
Fanetti, Ilaria ;
Borghi, Marta ;
Soffredini, Roberta ;
Iavarone, Massimo ;
Tosetti, Giulia ;
Perbellini, Riccardo ;
Sangiovanni, Angelo ;
Sypsa, Vana ;
Lampertico, Pietro .
JOURNAL OF HEPATOLOGY, 2022, 76 (02) :302-310
[10]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231